Public Assessment Report of the Reclassification of Almerg (fexofenadine) 180mg film-coated tablets

The MHRA considers this product sufficiently safe to be sold as Pharmacy medicine for relief of symptoms associated with chronic idiopathic urticaria in adults and children aged 12 years and over. This report outlines the evidence reviewed that led to this decision.

Source:

Medicines and Healthcare products Regulatory Agency